Lisinopril Tablet
Product Images NDC 60760-358

2 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 60760-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)
Chemical structure diagram depicting the molecular layout of Lisinopril, the active ingredient in the product LISINOPRIL 10 mg oral tablets by St. Mary's Medical Park Pharmacy. The structure includes various functional groups and indicates the presence of two water molecules (dihydrate).*
FDA Label Image

358 (Lisinopril 10mg 30ct 60760 358 30)

358 (Lisinopril 10mg 30ct 60760 358 30)
Lisinopril Tablets USP 10 mg bottle label showing drug name, strength, and quantity of 30 tablets. Label indicates manufacturer Zhejiang Huahai Pharmaceutical Co., Ltd and the labeler St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes storage instructions, dosage note to see full prescribing information, and child-resistant container warning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.